Jane Street’s Tenax Therapeutics TENX Stock Holding History

Jane Street’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.88M	Buy	266,656 +233,028	+693%	+$2.98M	﹤0.01%	4090
2026 Q1	$538K	Buy	+33,628	New	+$455K	﹤0.01%	7881
2019 Q2	–	Sell	-12	Closed	-$39K	–	5727
2019 Q1	$39K	Buy	+12	New	+$27.4K	﹤0.01%	4854
2014 Q2	–	Sell	-1	Closed	-$139K	–	3105
2014 Q1	$139K	Buy	+1	New	+$198K	﹤0.01%	2460
2013 Q4	–	Hold	0	–	–	–	2218

Other funds holding TENX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jane Street's TENX Position: Q2 2026 in Review

Jane Street increased its Tenax Therapeutics (TENX) stake by 693% in Q2 2026, buying an estimated $2.98M and bringing the position to 266,656 shares worth $3.88M. The position accounts for ﹤0.01% of the portfolio, ranked #4090.

Jane Street first reported a position in TENX in Q1 2014 and has held it in 4 quarters since. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

Jane Street held 266,656 shares of Tenax Therapeutics worth $3.88M as of Q2 2026.
Jane Street bought 233,028 Tenax Therapeutics shares in Q2 2026, an estimated $2.98M.
Tenax Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4090 holding.
Jane Street first reported a position in Tenax Therapeutics in Q1 2014 and has held it in 4 quarters since.
111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.